These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 5563336)

  • 21. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The therapeutic uses of calcitonin.
    Martin TJ
    Scott Med J; 1978 Apr; 23(2):161-5. PubMed ID: 644299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paget disease of bone. Long-term treatment with salmon calcitonin.
    Schuhmacher CA; Scurry MT; Deiss WP
    Arch Intern Med; 1973 May; 131(5):722-4. PubMed ID: 4735644
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease].
    Lo Cascio V; Lechi C; Adami S; Bianchi I; Cominacini L; Galvanini G
    Boll Soc Ital Biol Sper; 1974 Jan; 50(1-2):55-61. PubMed ID: 4425587
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of calcitonin therapy in deafness associated with Paget's disease of bone.
    Moffatt WH; Morrow JD; Simpson N
    Br Med J; 1974 Oct; 4(5938):203. PubMed ID: 4418661
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of results obtained with thyrocalcitonin, in particular, with a radiodensitometric bone technic].
    Simon L; Regal R; Rossi M; Claustre J; Blotman F
    Rev Rhum Mal Osteoartic; 1973 Nov; 40(11):659-63. PubMed ID: 4775216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary bone dysplasia with hyperphosphatasaemia: response to synthetic human calcitonin.
    Horwith M; Nunez EA; Krook L; Viteri F; Torun B; Mena E; Suh SM; Eisenberg E; MacIntyre I; Whalen JP
    Clin Endocrinol (Oxf); 1976; 5 Suppl():341S-352S. PubMed ID: 1052783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiocalcium studies on the initial effects of calcitonin in man.
    Caniggia A; Gennari C
    Strahlentherapie Sonderb; 1975; 74():309-13. PubMed ID: 1198657
    [No Abstract]   [Full Text] [Related]  

  • 31. [Morbus Paget].
    Haas HG
    Dtsch Med Wochenschr; 1971 Aug; 96(35):1412. PubMed ID: 5565975
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of the prolonged treatment of simple osteoporosis with porcine calcitonin].
    Kuntz D; Teyssedou JP; Amouroux J; Bordier P; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1973 Oct; 40(10):565-71. PubMed ID: 4203406
    [No Abstract]   [Full Text] [Related]  

  • 33. Parathyroid function during treatment with salmon calcitonin.
    Chapuy MC; David L; Meunier PJ
    Horm Metab Res; 1980 Sep; 12(9):486-7. PubMed ID: 7429419
    [No Abstract]   [Full Text] [Related]  

  • 34. First therapeutic use of calcitonin.
    Milhaud G
    Bone Miner; 1992 Mar; 16(3):201-10. PubMed ID: 1562820
    [No Abstract]   [Full Text] [Related]  

  • 35. [Osteitis deformans].
    Pape K
    Stomatol DDR; 1978 Feb; 28(2):112-9. PubMed ID: 274833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcitonin and calcium in the treatment of Paget's disease of bone (author's transl)].
    Rico Lenza H; Huertas García-Alejo R; Gómez Castresana F; Espinós Pérez D
    Med Clin (Barc); 1982 Mar 1-15; 78(5):179-82. PubMed ID: 7078307
    [No Abstract]   [Full Text] [Related]  

  • 37. [Calcitonin an XXVI. Value of replacement doses in daily practice].
    Milhaud G; Pitovic R
    Therapie; 1992; 47(1):29-34. PubMed ID: 1523591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P; Lévy P
    Rev Rhum Mal Osteoartic; 1967 Apr; 34(4):185-92. PubMed ID: 6059924
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcitonin 1975.
    Milhaud G
    Biomedicine; 1976 Jun; 24(3):159-62. PubMed ID: 791386
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Calcitonin in steroid-induced osteoporosis.
    Palmieri GM; Dvorak J; Bottomley R
    N Engl J Med; 1974 Jun; 290(26):1490-1. PubMed ID: 4831772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.